Owing to a glitch at ASX Anatara was misspelt on the upcoming IPO list and also on its link http://anataralifesciences.com/ - and that continued on to its listing on this site. Consequently there has been no chat about ANR and it looks a worthy listing.
It plans to re-release a product called "Detach" - which worked very well and sold successfully for agro-chem company Ciba-Geigy until it was dropped during a company reorganisation.
Detach's active ingredient is Bromelain, an enzyme extracted from the Pineapple plant, with a variety of useful functions. It has been formulated in this instance to prevent scours - or diarrhoea - in animals. It's target market initially will be the Pork industry, where it has proven effect in significantly reducing mortality rate and improving food to weight ratio. It is a one dose item and represents a significant cost saving for pig breeders with a worldwide market of billions. Detach works by inhibiting the bad bugs from attaching themselves to an animals (or a humans) stomach lining. It is a safe affordable and effective cure for diarrhoea and it has enormous scope worldwide both in agribusiness and also in human health.
If readers are going to have a crack at this IPO they need to move fast as the offer closes next Friday the 3rd of October and there is no option to apply online - so you'll need to print up your prospectus (pages 120 and 121) http://anataralifesciences.com/investors/prospectus/ and effect payment smartly.
